Literature DB >> 20460046

[Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].

Long-man Li1, Xiao-yun Zeng, Long Ji, Xue-jiao Fan, Yong-qiang Li, Xiao-hua Hu, Xiao-qiang Qiu, Hong-ping Yu.   

Abstract

OBJECTIVE: To investigate whether the polymorphism of DNA repair genes XPC (Ala499Val and Lys939Gln) and XPG (His1104Asp) is associated with the susceptibility to hepatocellular carcinoma (HCC).
METHODS: A hospital-based case-control study was conducted in 500 cases with HCC and 507 controls. Genotypes of XPC and XPG were determined by real-time polymerase chain reaction with the TaqMan MGB probe.
RESULTS: Compared to the CC genotype, the CT genotype and the TT genotype of XPC Ala499Val were not associated with the susceptibility to HCC (adjusted OR = 1.34, 95% CI: 0.85-2.12; adjusted OR = 1.30, 95% CI: 0.68-2.51, respectively). Compared to the AA genotype, the AC genotype and the CC genotype of Lys939Gln were not associated with the susceptibility to HCC (adjusted OR = 1.20, 95% CI: 0.78-1.85; adjusted OR = 1.81, 95% CI: 0.88-3.73, respectively). Compared to the CC genotype, the CG genotype and the GG genotype of XPG His1104Asp were not associated with the susceptibility to HCC (adjusted OR = 0.85, 95% CI: 0.56-1.27; adjusted OR = 1.12, 95% CI: 0.67-1.87, respectively) However, the stratified analysis revealed that the females with the AC+CC genotype of XPC Lys939Gln had increased risk of HCC compared to those with AA genotype (OR = 2.17, 95% CI: 1.01-4.64).
CONCLUSION: Our results suggest that XPC and XPG polymorphisms do not independently affect on the susceptibility to HCC, but the joint effect of C allele of XPC Lys939Gln and female may modify the risk of HCC.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20460046     DOI: 10.3760/cma.j.issn.1007-3418.2010.04.009

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  9 in total

1.  XPC Ala499Val and XPG Asp1104His polymorphisms and digestive system cancer risk: a meta-analysis based on model-free approach.

Authors:  Guangsheng Yu; Jianlu Wang; Jiahong Dong; Jun Liu
Journal:  Int J Clin Exp Med       Date:  2015-04-15

2.  XPG Asp1104His polymorphism and gastrointestinal cancers risk: a meta-analysis.

Authors:  Jian-Fei Luo; Rui-Cheng Yan; Li Zou
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Association of a p73 exon 2 G4C14-to-A4T14 polymorphism with risk of hepatocellular carcinoma in a Chinese population.

Authors:  Benyuan Deng; Fei Liu; Yonggang Wei; Limei Luo; Xi Chen; Lvnan Yan; Bo Li
Journal:  Tumour Biol       Date:  2012-10-12

4.  XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.

Authors:  Xia Jiang; Li-Tao Zhou; Shan-Chun Zhang; Kun Chen
Journal:  Chin J Cancer Res       Date:  2012-09       Impact factor: 5.087

5.  Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.

Authors:  Mei-Ling Zhu; Mengyun Wang; Zhi-Gang Cao; Jing He; Ting-Yan Shi; Kai-Qin Xia; Li-Xin Qiu; Qing-Yi Wei
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

6.  Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis.

Authors:  Xiao-Feng He; Li-Rong Liu; Wu Wei; Yi Liu; Jiao Su; Su-Lan Wang; Xu-Liang Shen; Xian-Bin Yang
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

7.  Diagnostic and prognostic values of the mRNA expression of excision repair cross-complementation enzymes in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Lu Yang; Ming Xu; Chuan-Bao Cui; Peng-Hai Wei; Shu-Zhi Wu; Zuo-Jie Cen; Xing-Xing Meng; Qiong-Guang Huang; Zhi-Chun Xie
Journal:  Cancer Manag Res       Date:  2018-11-05       Impact factor: 3.989

8.  XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies.

Authors:  Jie Zhao; Shanshan Chen; Haixia Zhou; Ting Zhang; Yang Liu; Jing He; Jinhong Zhu; Jichen Ruan
Journal:  Aging (Albany NY)       Date:  2018-05-20       Impact factor: 5.682

9.  Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.

Authors:  Yingqi Dai; Zhonghua Song; Jinqing Zhang; Wei Gao
Journal:  Biosci Rep       Date:  2019-12-20       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.